If you're like me, we're all wondering what is going to occur with ACA (Obamacare) once Donald Trump takes office and the charts from Healthcare (XLV) and Biotech (XBI) certainly reflect the concern. With the proposed 21st Century Cures Act, due for Senate passage this week, be the $5Billion dollar "game changer" the sector is waiting for...........or will we be waiting until Congress replaces the unpopular components of Obamacare to see an impact in stock price?
Repealing or replacing Obamacare is fraught with at least six major issues, but perhaps the most significant one is a lack of decisiveness within the Republican party itself. What would Obamacare be replaced with, and how would that change be implemented?
Interestingly, there are at least seven Republican plans that have been tabled to replace Obamacare. Within that group, two of the more prominent ones come from Georgia Rep. Tom Price and House Speaker Paul Ryan.
Tom Price, who is Trump’s pick as the incoming secretary for the Department of Health and Human Services (HHS), has already published his consumer-driven healthcare model, and it already exists in legal language. In additional, Paul Ryan released his own proposal in the form of the A Better Way plan earlier this year, which also touches on other issues such as poverty, national security, and the economy.
Despite the number of options, the problem is that no one can agree on a particular solution. The party is heavily divided, and Trump is already receiving heavy blowback from the Tea Party faction for telegraphing potential delays in repealing or replacing the act.
Yes, the future of U.S. healthcare is murky – even to Trump and the GOP. However, what is clear is that with most chips stacked in the Republicans favor over the coming years, it is unlikely that they will miss the opportunity to initiate the post-Obamacare era in some shape or form.